Unlocking value potential for a client’s rare disease treatment
In this use case, learn how MMIT, powered by NorstellaLinQ, translated complex RWD into actionable strategies to help the client achieve business growth while advancing equity and patient access.
Addressing cost barriers and enhancing medicare access strategies to improve commercialization strategy
In this use case, learn how MMIT, powered by NorstellaLinQ, translated complex RWD into actionable insights which helped the client tackle affordability and access challenges in a complex therapeutic area.
Innovation trends from R&D to market access
2024 has been an incredibly busy year for Norstella as its constituent organizations – Citeline, Evaluate, MMIT, Panalgo, and the Dedham Group – have continued to support the biopharma ecosystem in bringing new therapies to patients. Throughout the course of the year, we have also shared our latest views on the issues that are most […]
Assessing AI transformation in pharma R&D: Current and future impact
Artificial intelligence (AI) has been one of the largest disruptors in drug development over the past few years, with the promise of innovation and greater efficiencies keeping the pharma industry heavily invested. There have been major advancements in AI-discovered molecules and AI-powered platforms for decentralized treatment, in addition to many more AI applications that have […]
Conference catch-up: Collaboration and innovation in biopharma
The biopharma industry is evolving, with increased focus on partnerships, early-phase deal-making and technologies like AI and machine learning. At this year’s BIO-Europe conference in Stockholm, Norstella’s subject matter experts joined discussions on key topics, including a roundtable on the future of precision medicine and a panel on the pharma patent cliff, highlighting the role […]
Level up your lab data: New use cases for improving time to treatment
This webinar explores how integrated laboratory and real-world data (RWD) are helping accelerate diagnosis, patient identification, clinical trial recruitment, and commercialization. Norstella and Quest Diagnostics highlight how linked claims, lab, EMR, and unstructured data support precision medicine, physician targeting, and earlier disease detection across oncology, neurology, rare disease, and autoimmune conditions. The discussion also covers […]
Conference catch-up: Navigating the evolving CDMO landscape
Contract development and manufacturing organizations (CDMOs) are reshaping pharmaceutical production, playing a pivotal role in supply chain stability and driving innovation. In today’s fast-evolving environment, CDMOs help life sciences companies enhance speed, flexibility, and efficiency, which ultimately advances access to life-saving therapies. To support this progress, Norstella provides tailored insights, tools and intelligence solutions that […]
Conference catch-up: The rise of digital therapeutics (part 2)
Health technologies are revolutionizing the ways in which life sciences organizations develop and deliver life-saving treatments to patients. In particular, digital therapeutics have become a prominent area of focus due to their potential to improve outcomes while reducing patient burden. Norstella continues to be proponent for these innovative technologies, partnering with organizations to launch their […]
The current & future impact of AI on pharmaceutical R&D
Artificial intelligence (AI) continues to disrupt existing paradigms in drug development, with early adopters experiencing both the benefits and challenges of this innovative technology. With that in mind, Norstella surveyed 125 senior decision-makers in the life sciences industry on their perceptions and expectations of AI to understand current AI adoption trends in addition to the […]
Norstella rolls out NorstellaLinQ data platform
Norstella LinQ establishes a throughline between the company’s various subsidiaries, utilizing capabilities from Citeline, Evaluate, MMIT, Panalgo and The Dedham Group. Norstella debuted its NorstellaLinQ data platform on Tuesday, an offering from the pharmaceutical intelligence solutions provider that aggregates and cleans real-world data from various sources to provide high quality, comprehensive patient information. Utilizing Norstella’s […]